Profile data is unavailable for this security.
About the company
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.
- Revenue in USD (TTM)72.07m
- Net income in USD-32.47m
- Incorporated2001
- Employees203.00
- LocationNeuronetics Inc3222 Phoenixville PikeMALVERN 19355United StatesUSA
- Phone+1 (610) 640-4202
- Fax+1 (610) 640-4206
- Websitehttps://neurostar.com/neuronetics/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orgenesis Inc | 662.00k | -29.02m | 25.81m | 146.00 | -- | -- | -- | 38.99 | -0.8684 | -0.8684 | 0.02 | -0.3303 | 0.0272 | 78.29 | 5.38 | 4,534.25 | -122.18 | -- | -1,312.10 | -- | -101.06 | -- | -4,489.28 | -- | 0.0741 | -5.85 | -- | -- | -98.53 | -50.94 | -271.82 | -- | -17.71 | -- |
| Femasys Inc | 950.09k | -16.69m | 26.01m | 32.00 | -- | 2.31 | -- | 27.38 | -0.8468 | -0.8468 | 0.0472 | 0.5060 | 0.0549 | 0.3438 | 7.65 | 29,690.31 | -96.51 | -- | -108.58 | -- | 65.67 | -- | -1,756.83 | -- | 5.93 | -77.25 | 0.2972 | -- | -11.13 | -- | -25.04 | -- | -- | -- |
| Meihua International Medical Tech Co Ltd | 97.10m | 11.63m | 26.22m | 617.00 | 2.12 | 0.1685 | 2.17 | 0.270 | 0.4856 | 0.4856 | 4.06 | 6.11 | 0.5788 | 46.66 | 1.31 | 157,372.60 | 6.91 | 12.26 | 8.13 | 15.05 | 34.19 | 38.14 | 11.94 | 15.47 | 5.21 | -- | 0.0475 | 0.00 | -6.05 | 5.10 | 86.22 | -5.56 | -9.16 | -- |
| Retractable Technologies Inc | 38.25m | -18.10m | 26.91m | 148.00 | -- | 0.3158 | -- | 0.7035 | -0.6046 | -0.6046 | 1.28 | 2.85 | 0.2202 | 1.44 | 6.42 | 258,468.00 | -10.28 | 12.45 | -10.79 | 14.51 | 19.19 | 40.82 | -46.71 | 18.09 | 6.54 | -2.86 | 0.016 | -- | -54.02 | 5.55 | -249.46 | -- | 17.42 | -- |
| Ekso Bionics Holdings Inc | 18.16m | -12.42m | 26.99m | 70.00 | -- | 1.91 | -- | 1.49 | -0.7909 | -0.7909 | 1.13 | 0.6538 | 0.5957 | 1.65 | 3.14 | 259,428.60 | -40.75 | -43.63 | -57.60 | -57.67 | 51.83 | 51.93 | -68.41 | -104.24 | 1.77 | -23.99 | 0.3172 | -- | 41.57 | 10.03 | -0.7825 | -- | 3.69 | -- |
| bioAffinity Technologies Inc | 7.32m | -8.74m | 27.12m | 75.00 | -- | 6.73 | -- | 3.71 | -0.9007 | -0.9007 | 0.7439 | 0.2989 | 0.9422 | 236.81 | 8.68 | 97,545.07 | -112.51 | -- | -140.58 | -- | 35.47 | -- | -119.41 | -- | 1.14 | -296.51 | 0.234 | -- | 52,660.42 | -- | 2.66 | -- | -- | -- |
| Positron Corp | 1.24m | -1.27m | 27.23m | 22.00 | -- | -- | -- | 22.01 | -0.0897 | -0.0897 | 0.0876 | -0.1109 | 0.5976 | 2.29 | 6.56 | -- | -61.35 | -224.13 | -- | -- | 32.98 | 9.85 | -102.67 | -201.87 | 0.0638 | -- | -- | -- | -10.06 | 0.2751 | 63.63 | -- | 4.36 | -- |
| Golden Valley Development Inc | 0.00 | -92.53k | 27.36m | 0.00 | -- | -- | -- | -- | -11.17 | -11.17 | 0.00 | -0.0211 | 0.00 | -- | -- | -- | -7,710.83 | -- | -- | -- | -- | -- | -- | -3,073.27 | -- | -3.96 | -- | -- | -- | -- | 45.48 | -- | -- | -- |
| Neuronetics Inc | 72.07m | -32.47m | 28.70m | 203.00 | -- | 1.47 | -- | 0.3983 | -1.10 | -1.10 | 2.45 | 0.6433 | 0.7309 | 2.31 | 4.76 | 355,000.00 | -32.93 | -28.02 | -42.47 | -34.73 | 75.91 | 75.73 | -45.06 | -51.04 | 2.37 | -3.92 | 0.755 | -- | 9.42 | 6.22 | 18.76 | -- | 18.57 | -- |
| Neuroone Medical Technologies Corp | 3.96m | -12.10m | 28.81m | 16.00 | -- | 8.65 | -- | 7.27 | -0.4916 | -0.4916 | 0.1593 | 0.1082 | 0.7428 | 1.69 | 19.31 | 247,702.50 | -226.84 | -172.88 | -334.70 | -274.74 | 29.60 | -- | -305.37 | -674.97 | 1.36 | -- | 0.00 | -- | 62.66 | -- | -18.60 | -- | -- | -- |
| Know Labs Inc | 0.00 | -16.34m | 29.68m | 15.00 | -- | -- | -- | -- | -0.2204 | -0.2204 | 0.00 | -0.0533 | 0.00 | -- | -- | 0.00 | -442.53 | -209.16 | -- | -1,087.76 | -- | -- | -- | -1,302.62 | -- | -15.98 | 6.21 | -- | -100.00 | -- | -1.85 | -- | -3.64 | -- |
| DarioHealth Corp | 19.15m | -46.52m | 30.03m | 223.00 | -- | 0.4411 | -- | 1.57 | -1.51 | -1.51 | 0.5803 | 2.27 | 0.16 | 2.39 | 3.31 | 69,373.19 | -42.46 | -73.26 | -47.52 | -87.59 | 30.97 | 29.54 | -265.33 | -293.54 | 1.96 | -- | 0.2961 | -- | -26.41 | 22.45 | 0.5091 | -- | 52.42 | -- |
| Outset Medical Inc | 116.43m | -159.18m | 30.95m | 480.00 | -- | 0.4511 | -- | 0.2658 | -3.14 | -3.14 | 2.29 | 1.32 | 0.3588 | 1.58 | 3.28 | 242,552.10 | -49.06 | -41.40 | -57.18 | -47.29 | 28.23 | 5.71 | -136.72 | -159.05 | 5.38 | -18.39 | 0.7417 | -- | 13.00 | 130.43 | -6.04 | -- | 14.27 | -- |
| IRIDEX Corp | 49.70m | -10.86m | 32.03m | 111.00 | -- | 7.52 | -- | 0.6444 | -0.6679 | -0.6679 | 3.06 | 0.2581 | 1.46 | 2.66 | 7.84 | 447,747.80 | -31.84 | -19.54 | -54.55 | -27.46 | 40.44 | 42.67 | -21.85 | -15.45 | 0.8599 | -- | 0.00 | -- | -8.96 | 4.02 | -26.81 | -- | -24.35 | -- |
Data as of Sep 20 2024. Currency figures normalised to Neuronetics Inc's reporting currency: US Dollar USD
40.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Cannell Capital LLCas of 30 Jun 2024 | 2.38m | 7.86% |
| Kent Lake Capital LLCas of 30 Jun 2024 | 1.74m | 5.74% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 1.29m | 4.26% |
| First Washington Corp.as of 30 Jun 2024 | 1.27m | 4.21% |
| Silvercrest Asset Management Group LLCas of 30 Jun 2024 | 1.19m | 3.94% |
| Balyasny Asset Management LPas of 30 Jun 2024 | 1.14m | 3.78% |
| First Eagle Investment Management LLCas of 30 Jun 2024 | 1.04m | 3.43% |
| Archon Capital Management LLCas of 12 Aug 2024 | 922.44k | 3.05% |
| G2 Investment Partners Management LLCas of 30 Jun 2024 | 681.46k | 2.25% |
| Millrace Asset Group, Inc.as of 30 Jun 2024 | 548.47k | 1.81% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
